The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Encouraging to see that John Gunn, a very wise and seasoned investor has been recently buying stock at what still look like ridiculously low levels if this company does indeed have the brilliant prospects (if very questionable management) that appear to exist.
Agree, we could certainly do with an update.
I notice another two large purchases 2 x 150k yesterday, which didn’t seem to affect the price – Can only assume any selling around this figure is being hoovered up by a large buyer – not sure if it TEK again selling as they can sell 1m shares (.73%) from last RNS, before another RNS re holding would need to be issued.
Time will tell!
Update fella
I assume because they have been busy making and selling so many they have forgotten!
Or… is it so bad they dare not release them for fear of giving 2 shares for every one of this new company
Oh, and before you tough northern folk start banging on about 100mph winds, to us wetties down in East Anglia, 40+ mph winds are scary and we are just not used to it!!! :)
Re late RNS – Buyer 457,000 & 100,000
MR JOHN HUMPHREY GUNN is a Venture Capitalist from Kidlington Oxfordshire. This person was born in January 1942, which was over 82 years ago. MR JOHN HUMPHREY GUNN is British and resident in United Kingdom. This company officer is, or was, associated with at least 67 company roles.
Gives me faith that a guy who has this much experience is buying, increasing holding to 2.99%
Yes, I know its early – gusts of 40+ mph woke me up!!!
Continuing to sell off the family silver for pennies.
They need cash to buy some Discov-R units I assume?
Https://www.lse.co.uk/rns/BELL/form-83-belluscura-plc-4y14k149ubd7p4r.html
Sold 3.5million shares
About £500k
How much more selling does TEK need to do ?
That's the conundrum with Bell. TEK can destroy it at any time, or at least until it's better established with a decent revenue stream.
It will be a better hold once TEK are fully out imho although to be fair it can happen any place, anytime with minnows, when there's a distressed seller involved
Prob Cliff
I wonder who just sold £600k worth at 16.15p?
19-1-24. New details about Belluscura's proposed acquisition of TMTA. https://www.voxmarkets.co.uk/articles/new-details-about-belluscura-s-proposed-acquisition-of-tmta-c2ac18d/
Belluscura's X-PLOR portable oxygen concentrator greenlit for Chinese market. Just doing a little research. It seems to all be coming together for the company. https://www.voxmarkets.co.uk/articles/belluscura-s-x-plor-portable-oxygen-concentrator-greenlit-for-chinese-market-1dbdc6e/
Only 3 months ago. 3-10-2023 approval for X-PLOR oxygen device in Hong Kong. https://www.med-technews.com/news/Medtech-Regulatory-News/belluscura-receives-approval-for-x-plor-oxygen-device-in-hon/
2-1-2024. Belluscura's portable oxygen concentrator approved for Singapore. https://www.med-technews.com/news/medical-device-news/belluscura-s-portable-oxygen-concentrator-approved-for-singa/
CM22
I thought I added balance!
Have a good weekend
laura
they were market leading in 2021.
they have spent two years making almost none. any they have made seem to have been discounted.
they have lied about orders delivered or sent. see 2023 new year updates followed by trading update mid year.
they fail to inform anyone of any delay, alteration, plan. their sums don’t add up and it seems to bother nobody.
the design of their kit has changed but there was no update on that and the cost affect. new materials needed, old materials rendered useless.
and recently they have paid massively over the odds to raise money. someone tanked the share price selling a few 100,000 shares.they new company used that as a reason to drive a better deal which stinks to high heaven.
both companies use same broker extracting huge fees.
essentially the good old shareholder gets treated like ****e here.
and this is it. if they mess this up they are dead and buried.
all that said. there is some demand not matched by anything other than one notable order.
they have medical clearance in a lot of places worldwide. eu expected this year i think.
so they have lots of market open to them.
they just have none to sell and despite having all year have seemingly made almost none of the first or second model.
there will be january trading update that will make it very clear how great the future is. ‘jam tomorrow’ is their byword. you will hear of ever expanding opportunities and markets and that this is the time to push on ‘with confidence’.
that is usually translated as ‘there will be another delay but we will let you know 5 months after everyone else’.
ron rauker will tell you ‘he likes to hit his numbers’ but there will be no evidence of any numbers being hit.
if you read their latest updates ‘direct to consumer sales have trebled’ but the lowly shareholder knows not whether that is one unit to three units or 1000 units to 3000 units.
you can therefore assume it is closer to one unit to three units because if it was 1000 to 3000 units they would tell us, the price wouldn’t tank as it has…. it would stabilise and the new team of crooks wouldn’t have the ability to screw us over.
whether other companies have something similar only time will tell but two years wasted producing not much other than opportunities.
for most of us, the best result is a good year followed by a takeover by a bigger better placed company. one who is not happy to give 98% of the company away in exchange for a signed photograph.
so…. i think the trading update will be dire. will barely mention sales. and the price will drop to 15p
1-2-1 parity with new company will remain
if you invest i’d wait for the trading update. if you invest set yourself an exit point that is actually reachable. if you are in at 19p i’d get out at 30. that is achievable
but you now have 25,000,000 new shares owned by wealthy people who are not locked in at all. and they
The deal set to close on March 1st is a reverse takeover with TMT and basically provides cash for BELL and shares for TMT. TMT is a vehicle of cash waiting to be allocated to some project. This case BELL. They have new terms of 1 for 1 share. That is if you own 1 share of TMT you receive 1 share of BELL. This is based on the share price at the time of 21p but it was only set at that level because TMT have been trying to drive down the Share price. I don't think it is very informative of what they see the value of BELL share price going forward.
Fair value is seen at over 100p but it is conditional on scaling up effectively and meeting analyst targets. It is covered by 2 analyst who has a price target of 124p. A couple of years ago it reached 136p when it was a lot smaller company, although financial conditions were a lot more favourable then.
Very many thanks
What "should "the deal on 1st March set as the floor price for BELL
Hi Laura2022,
I think a good place to start is reading this:
https://www.investorschronicle.co.uk/ideas/2023/09/01/profit-from-medtech-growth-with-this-undervalued-stock/
and this
https://theoakbloke.substack.com/p/bell-onging-together?utm_source=%2Fsearch%2Fbelluscura&utm_medium=reader2
To summarize, BELL have market leading products and massive demand. They actually have demand far outpacing the production that they can reach in the near term. The problem has been the financing to scale up. TMT have been messing the company around the last 3 months. However, it looks like it might be settled soon with March 1st the new date for completion of the deal.